Skip to main content
Premium Trial:

Request an Annual Quote

PE Biosystems to Acquire Third Wave for $325 Million

Premium

F

OSTER CITY, Calif.--PE Biosystems Group is set to acquire Third Wave Technologies for $325.1 million in stock, according to a Bloomberg News report. PE Biosystems will give up 1.97 million common shares for the six-year old company with 120 employees in Madison, Wis. The PE subsidiary will get Third Wave’s Invader nucleic acid detection technology, which it hopes will accelerate its pharmacogenomics efforts in identifying which genes are involved in specific diseases, and how patients might respond to certain treatments.

Third Wave recently announced that it is collaborating with the Sanger Centre to use Invader to construct the first high-density SNP map of a human chromosome (chromsome 22) and corresponding SNP test panel.

Filed under

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.